Loading...

Medlab Clinical Limited

MDC.AXASX
Healthcare
Biotechnology
A$6.60
A$0.00(0.00%)

Medlab Clinical Limited (MDC.AX) Company Profile & Overview

Explore Medlab Clinical Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Medlab Clinical Limited (MDC.AX) Company Profile & Overview

Medlab Clinical Limited, a biotechnology company, researches, develops, and pre-commercializes pharmaceutical and nutraceutical products in Australia. Its drug candidate includes NanaBis, a buccal spray from cannabis oil extract for oncology and pain management; and NanoCBD, a buccal spray from hemp oil extract for mental health. The company also develops NanoCelle, a patented sub-micron drug delivery platform that allows passive diffusion of active pharmaceutical ingredients directly into the bloodstream through oral-buccal, sublingual, intranasal, and transdermal or topical delivery. In addition, it offers virtual clinic services. The company was founded in 2012 and is headquartered in Botany, Australia.

SectorHealthcare
IndustryBiotechnology
CEOSean Michael Hall

Contact Information

61 2 8188 0311
Building A, Botany, NSW, 2019

Company Facts

14 Employees
IPO DateJul 14, 2015
CountryAU

Frequently Asked Questions

;